Michael Mengel

Title: Michael Mengel - Innovator in Gastrointestinal Tumor Monitoring

Introduction

Michael Mengel is a notable inventor based in Munich, Germany. He has made significant contributions to the field of medical diagnostics, particularly in the monitoring and prognosis of gastrointestinal tumors. His innovative approach has the potential to enhance patient care and treatment outcomes.

Latest Patents

Michael Mengel holds a patent for a method that focuses on the diagnosis, monitoring, and prognostication of the disease course of gastrointestinal tumors. This invention involves determining the level of a cyclin-dependent kinase inhibitor (CK1) in a sample. The method allows for diagnosing the disease and/or its recurrence, as well as prognosticating the disease course based on the CK1 levels in the examined tumor cells. Additionally, the invention includes test kits designed for research and diagnostic purposes.

Career Highlights

Michael Mengel is associated with Mtm Laboratories, Ag, where he applies his expertise in medical research and innovation. His work is pivotal in developing methods that can lead to more effective therapies for patients suffering from gastrointestinal tumors.

Collaborations

Michael has collaborated with esteemed colleagues such as Peter Martin and Reinhard Von Wasielewski. Their combined efforts contribute to advancing research in the field of oncology.

Conclusion

Michael Mengel's innovative work in the diagnosis and treatment of gastrointestinal tumors exemplifies the impact of dedicated inventors in the medical field. His contributions are vital for improving patient outcomes and advancing medical technology.